We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
-4.48%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$387B
AUM Growth
-$17.5B
Cap. Flow
+$4.4B
Cap. Flow %
1.14%
Top 10 Hldgs %
31.87%
Holding
14,936
New
2,168
Increased
5,454
Reduced
5,272
Closed
1,852

Sector Composition

Rank Sector Weight
1 Miscellaneous 92.17%
2 Technology 1.87%
3 Consumer Discretionary 1.66%
4 Communication Services 1.09%
5 Financials 1.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OSG
11051
Octave Specialty Group
OSG
$209M
$162K ﹤0.01%
12,714
-155,605
-92% -$2.07M
GAIN icon
11052
PUT
Gladstone Investment Corp
GAIN
$654M
$162K ﹤0.01%
13,400
-4,800
-26% -$69K
NERV icon
11053
CALL
Minerva Neurosciences
NERV
$231M
$162K ﹤0.01%
17,600
-41,800
-70% -$248K
QUIK icon
11054
PUT
QuickLogic
QUIK
$198M
$162K ﹤0.01%
25,000
-300
-1% -$2.23K
RNAC icon
11055
CALL
Cartesian Therapeutics
RNAC
$290M
$162K ﹤0.01%
+3,283
New +$180K
THR
11056
DELISTED
Thermon Group Holdings
THR
$162K ﹤0.01%
+10,540
New +$173K
SEEL
11057
CALL
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$162K ﹤0.01%
41
-55
-57% -$216K
AAC.U
11058
DELISTED
Ares Acquisition Corporation Units, each consisting of one Class A ordinary share, and one-fifth of one redeemable warrant
AAC.U
$162K ﹤0.01%
+16,318
New +$162K
BV icon
11059
BrightView Holdings
BV
$1.04B
$161K ﹤0.01%
20,235
-100,689
-83% -$1.08M
HUMA icon
11060
CALL
Humacyte
HUMA
$181M
$161K ﹤0.01%
49,400
+28,900
+141% +$111K
RCKT icon
11061
PUT
Rocket Pharmaceuticals
RCKT
$424M
$161K ﹤0.01%
+10,100
New +$158K
RETL icon
11062
CALL
Direxion Daily Retail Bull 3X ETF
RETL
$25.7M
$161K ﹤0.01%
26,300
+7,300
+38% +$69.1K
SEER icon
11063
PUT
Seer Inc
SEER
$110M
$161K ﹤0.01%
20,800
-1,800
-8% -$17.5K
VLY icon
11064
PUT
Valley National Bancorp
VLY
$7.69B
$161K ﹤0.01%
14,900
-5,800
-28% -$66.9K
BODI icon
11065
PUT
The Beachbody Company
BODI
$42.5M
$161K ﹤0.01%
3,180
-740
-19% -$47K
CNH
11066
CNH Industrial
CNH
$18.8B
$161K ﹤0.01%
+14,425
New +$174K
LTRN icon
11067
PUT
Lantern Pharma
LTRN
$26.5M
$160K ﹤0.01%
+33,500
New +$180K
NQP
11068
DELISTED
Nuveen Pennsylvania Quality Municipal Income Fund
NQP
$160K ﹤0.01%
+14,596
New +$177K
HTT
11069
High Templar Tech Ltd
HTT
$408M
$160K ﹤0.01%
177,390
+72,356
+69% +$77.5K
RXRX icon
11070
PUT
Recursion Pharmaceuticals
RXRX
$1.79B
$160K ﹤0.01%
15,000
-11,800
-44% -$120K
TLYS icon
11071
Tilly's
TLYS
$121M
$160K ﹤0.01%
+23,170
New +$176K
VRNA
11072
PUT
DELISTED
Verona Pharma
VRNA
$160K ﹤0.01%
+15,700
New +$132K
CALT
11073
CALL
DELISTED
Calliditas Therapeutics AB American Depositary Shares
CALT
$160K ﹤0.01%
+10,600
New +$185K
EOPS
11074
DELISTED
Emles Alpha Opportunities ETF
EOPS
$160K ﹤0.01%
+12,336
New +$182K
CGEM icon
11075
CALL
Cullinan Oncology
CGEM
$1.4B
$159K ﹤0.01%
+12,400
New +$167K

Similar funds

Jeff Yass's Q3 2022 Portfolio in Review

As of Q3 2022, Jeff Yass held 14,936 positions worth $387B, down 4.3% from $404B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Jeff Yass's Q3 2022 filing shows 2,168 new, 5,454 increased, 5,272 reduced and 1,852 closed positions. Its largest new stake was Vanguard Short-Term Corporate Bond ETF: 714,572 shares worth $53.1M. The largest sale was Tesla, an estimated $799M.

By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, down from 92% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jeff Yass's largest Q3 2022 buy was Vanguard Short-Term Corporate Bond ETF: 714,572 shares worth $53.1M.
  • Jeff Yass added most to Amazon in Q3 2022, an estimated $1.21B increase.
  • Jeff Yass's biggest Q3 2022 reduction was Tesla, cutting an estimated $799M.
  • Jeff Yass fully exited Pershing Square Tontine Holdings, Ltd. in Q3 2022, selling an estimated $151M.
  • Jeff Yass's ten largest holdings make up 32% of its $387B portfolio in Q3 2022.
  • Jeff Yass opened 2,168 new positions and closed 1,852 in Q3 2022.
  • Jeff Yass's portfolio value fell 4.3% quarter-over-quarter to $387B.

Based on Susquehanna International Group's 13F filing for Q3 2022, filed 14 Nov 2022.